CIR Proposes Prioritizing Triclosan For Review In 2018
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review Expert Panel’s draft ingredient priority list for 2018 review consists of 14 ingredients, including triclosan. At their April meeting, panelists cited the potential for consumer confusion following recent FDA action banning the ingredient’s OTC use in antibacterial soaps, as well as endocrine-disruption concerns voiced by NGOs.
You may also be interested in...
CIR Expert Panel Finalizes 2018 Review Priorities At June Meeting
Fourteen cosmetic ingredients are up for first looks by the CIR panel in 2018. Also at its June meeting, the group issued two final ingredient reports and five tentative reports, as well as two insufficient data announcements, and tabled its parabens re-review in order to solicit outside expertise on new DART data.
CIR Slated To Examine New Paraben Data At Next Meeting
The Cosmetic Ingredient Review Expert Panel will take another look at paraben safety during its June meeting, considering new studies and adding ingredients to its assessment on the preservative group. NGO Women’s Voices for the Earth suggests that the panel may still be missing several relevant studies.
ACI Has $10M Plan For Supporting Antibac Ingredients, If FDA Hasn’t Already Closed The Door
The American Cleaning Institute is working to provide FDA with requested data to support three antibacterial agents that remain potentially viable for OTC use in consumer hand soaps following a September final rule that determined triclosan and 18 other such ingredients non-GRASE. However, FDA’s recent messaging around the issue – including that antibacterial soaps “may do more harm than good” – isn’t helping, it says.